Asthma: NICE recommends LTRA tablets over combination inhaler
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
The new NICE draft guideline on asthma management currently under consultation recommends leukotriene receptor antagonist (LTRA) tablets over combination inhaler therapy in a move to boost savings for the NHS.
Newly diagnosed patients with asthma should be offered a short-acting beta2 agonist (SABA) to relieve symptoms as and when they occur.
A low-dose inhaled corticosteroid (ICS) is suitable as maintenance therapy for patients with symptoms uncontrolled by SABA.
If symptoms remain uncontrolled with ICS, patients should be offered an LTRA along with ICS before considering the combination (LABA + ICS)...